North America PCR-based Infectious Diseases Market to 2032
Overview
The North America PCR-based Infectious Diseases Market is expected to reach a 2.65 USD Billion by 2032 and is projected to grow at a CAGR of 9.11% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.51
Forecast, 2032 (USD Billion)
2.65
CAGR, 2024 - 2032
9.11%
Report Coverage
North America
North America PCR-based Infectious Diseases Market 2018-2032 USD Billion
North America PCR-based Infectious Diseases Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.51 USD Billion
- Projected Market Size (2032): 2.65 USD Billion
- CAGR (2025-2032): 9.11%
Key Findings of North America PCR-based Infectious Diseases Market
- The North America PCR-based Infectious Diseases Market was valued at 1.51 USD Billion in 2024.
- The North America PCR-based Infectious Diseases Market is likely to grow at a CAGR of 9.11% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Laboratory Based Testing in Testing Segment accounted for the largest share of the market with a revenue of 0.93 USD Billion
- The fastest growing segment Tuberculosis PCR Test in Test Type Segment grew Fastest with a CAGR of 11.82% during the forecast period from 2024 to 2032.
North America PCR-based Infectious Diseases Market Scope
North America PCR-based Infectious Diseases Market Segmentation & Scope
Test Type
- Others PCR Test
- Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
- Mycoplasma Genitalium (Mg) PCR Test
- Enterococcus PCR Test
- Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
- C.Difficile (Clostridium Difficile) PCR Test
- Norovirus PCR Test
- Sars (Covid-19) PCR Test
- H. Pylori PCR Test
- Bordetella PCR Test
- Rotavirus PCR Test
- Salmonellosis PCR Test
- Gonorrhea PCR Test
- Chlamydia Trachomatis Genital PCR Test
- Human Papillomavirus (Hpv) PCR Test
- Influenza PCR Test
- Human Immunodeficiency Virus (Hiv) PCR Test
- Hepatitis PCR Test
- Tuberculosis PCR Test
End User
- Others
- Home Healthcare
- Academic And Research Institutes
- Community Health Centers
- Clinics
- Hospital
- Diagnostic Centers
Testing
- Point of Care Testing
- Laboratory Based Testing
Patient Type
- Adults
- Pediatric
- Geriatric
PCR Technology
- Others
- Multiplex PCR
- RT PCR
Pathogen
- Others
- Protozoa
- Fungal
- Bacterial
- Viral
Infection
- Other Infections
- Hospital Acquired Infections
- Sexually Transmitted infection
- Respiratory Tract Infection
- Viral Infection
North America PCR-based Infectious Diseases Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.51 USD Billion |
| Market Value in 2032 | 2.65 USD Billion |
| CAGR (2025-2032) | 9.11% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Test Type,End User,Testing,Patient Type,PCR Technology,Pathogen,Infection |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 1.51 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 839.97 USD Million in 2024.
Segments and Scope
-
North America PCR-based Infectious Diseases Market to 2032, By Test Type
- Tuberculosis PCR Test is the largest segment in North America PCR-based Infectious Diseases Market to 2032 with a revenue of 166.90 USD Billion in the year 2024.
- Tuberculosis PCR Test is the Fastest growing segment in North America PCR-based Infectious Diseases Market to 2032 with a Growth rate of 11.82 % in forecast period 2025-2032.
-
North America PCR-based Infectious Diseases Market to 2032, By End User
- Diagnostic Centers is the largest segment in North America PCR-based Infectious Diseases Market to 2032 with a revenue of 375.32 USD Billion in the year 2024.
- Diagnostic Centers is the Fastest growing segment in North America PCR-based Infectious Diseases Market to 2032 with a Growth rate of 10.94 % in forecast period 2025-2032.
-
North America PCR-based Infectious Diseases Market to 2032, By Testing
- Laboratory Based Testing is the largest segment in North America PCR-based Infectious Diseases Market to 2032 with a revenue of 929.18 USD Billion in the year 2024.
- Laboratory Based Testing is the Fastest growing segment in North America PCR-based Infectious Diseases Market to 2032 with a Growth rate of 9.39 % in forecast period 2025-2032.
-
North America PCR-based Infectious Diseases Market to 2032, By Patient Type
- Geriatric is the largest segment in North America PCR-based Infectious Diseases Market to 2032 with a revenue of 612.18 USD Billion in the year 2024.
- Geriatric is the Fastest growing segment in North America PCR-based Infectious Diseases Market to 2032 with a Growth rate of 9.92 % in forecast period 2025-2032.
-
North America PCR-based Infectious Diseases Market to 2032, By PCR Technology
- RT PCR is the largest segment in North America PCR-based Infectious Diseases Market to 2032 with a revenue of 613.51 USD Billion in the year 2024.
- RT PCR is the Fastest growing segment in North America PCR-based Infectious Diseases Market to 2032 with a Growth rate of 9.95 % in forecast period 2025-2032.
-
North America PCR-based Infectious Diseases Market to 2032, By Pathogen
- Viral is the largest segment in North America PCR-based Infectious Diseases Market to 2032 with a revenue of 591.45 USD Billion in the year 2024.
- Viral is the Fastest growing segment in North America PCR-based Infectious Diseases Market to 2032 with a Growth rate of 9.54 % in forecast period 2025-2032.
-
North America PCR-based Infectious Diseases Market to 2032, By Infection
- Viral Infection is the largest segment in North America PCR-based Infectious Diseases Market to 2032 with a revenue of 603.56 USD Billion in the year 2024.
- Viral Infection is the Fastest growing segment in North America PCR-based Infectious Diseases Market to 2032 with a Growth rate of 9.85 % in forecast period 2025-2032.
North America PCR-based Infectious Diseases Market Company Share Analysis
North America PCR-based Infectious Diseases Market Geographical Sales Distribution, 2018-2032 USD Billion
North America PCR-based Infectious Diseases Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America PCR-based Infectious Diseases Market is segmented based on Segmentation Test Type,End User,Testing,Patient Type,PCR Technology,Pathogen,Infection.
North America PCR-based Infectious Diseases Market was valued at USD 1.51(Revenue in USD Billion) in 2022.
North America PCR-based Infectious Diseases Market is projected to grow at a CAGR of 9.11% during the forecast period of 2024 to 2032.
The Laboratory Based Testing segment is expected to dominate the North America PCR-based Infectious Diseases Market, holding a largest market share of 0.93 USD Billion in 2024
North America PCR-based Infectious Diseases Market Scope
North America PCR-based Infectious Diseases Market Segmentation & Scope
Test Type
- Others PCR Test
- Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
- Mycoplasma Genitalium (Mg) PCR Test
- Enterococcus PCR Test
- Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
- C.Difficile (Clostridium Difficile) PCR Test
- Norovirus PCR Test
- Sars (Covid-19) PCR Test
- H. Pylori PCR Test
- Bordetella PCR Test
- Rotavirus PCR Test
- Salmonellosis PCR Test
- Gonorrhea PCR Test
- Chlamydia Trachomatis Genital PCR Test
- Human Papillomavirus (Hpv) PCR Test
- Influenza PCR Test
- Human Immunodeficiency Virus (Hiv) PCR Test
- Hepatitis PCR Test
- Tuberculosis PCR Test
End User
- Others
- Home Healthcare
- Academic And Research Institutes
- Community Health Centers
- Clinics
- Hospital
- Diagnostic Centers
Testing
- Point of Care Testing
- Laboratory Based Testing
Patient Type
- Adults
- Pediatric
- Geriatric
PCR Technology
- Others
- Multiplex PCR
- RT PCR
Pathogen
- Others
- Protozoa
- Fungal
- Bacterial
- Viral
Infection
- Other Infections
- Hospital Acquired Infections
- Sexually Transmitted infection
- Respiratory Tract Infection
- Viral Infection
Frequently Asked Questions
The North America PCR-based Infectious Diseases Market is segmented based on Segmentation Test Type,End User,Testing,Patient Type,PCR Technology,Pathogen,Infection.
North America PCR-based Infectious Diseases Market was valued at USD 1.51(Revenue in USD Billion) in 2022.
North America PCR-based Infectious Diseases Market is projected to grow at a CAGR of 9.11% during the forecast period of 2024 to 2032.
The estimated market value of the North America PCR-based Infectious Diseases Market for final year is USD 2.65 (USD Billion).
North America PCR-based Infectious Diseases Market Company Profiling
Frequently Asked Questions
The North America PCR-based Infectious Diseases Market is segmented based on Segmentation Test Type,End User,Testing,Patient Type,PCR Technology,Pathogen,Infection.
North America PCR-based Infectious Diseases Market was valued at USD 1.51(Revenue in USD Billion) in 2022.
North America PCR-based Infectious Diseases Market is projected to grow at a CAGR of 9.11% during the forecast period of 2024 to 2032.
The estimated market value of the North America PCR-based Infectious Diseases Market for final year is USD 2.65 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.